Related Experiment Video
Updated: Aug 11, 2026
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei
David M Waag1, Michael J McCluskie, Ningli Zhang
1Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, MD 21702-5011, USA. david.waag@amedd.army.mil
Abstract:
Treatment with an oligodeoxynucleotide (ODN) containing CPG motifs (CpG ODN 7909) was found to protect BALB/c mice from lung infection or death after aerosol challenge with Burkholderia mallei. Protection was associated with enhanced levels of gamma interferon (IFN-gamma)-inducible protein 10, interleukin-12 (IL-12), IFN-gamma, and IL-6. Preexposure therapy with CpG ODNs may protect victims of a biological attack from glanders.
Insights
Oligodeoxynucleotides (ODNs) containing CPG motifs protected mice against Burkholderia mallei infection. This CpG ODN therapy enhanced immune responses, suggesting potential protection against glanders, a serious biological threat.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Glanders, caused by Burkholderia mallei, is a severe infectious disease with significant bioterrorism potential.
- Current treatments for B. mallei infection are limited, necessitating the exploration of novel therapeutic strategies.
Purpose of the Study:
- To evaluate the protective efficacy of CpG oligodeoxynucleotides (ODNs) against Burkholderia mallei infection in a mouse model.
- To investigate the immune mechanisms underlying the protective effects of CpG ODN therapy.
Main Methods:
- BALB/c mice were challenged with aerosolized Burkholderia mallei.
- Mice were pretreated with CpG ODN 7909, a specific oligodeoxynucleotide containing CPG motifs.
- Immune responses, including cytokine levels, were measured post-infection.
Main Results:
- CpG ODN 7909 treatment significantly protected mice from lung infection and mortality caused by B. mallei.
- Protection was correlated with elevated levels of key immune mediators: gamma interferon (IFN-γ)-inducible protein 10, interleukin-12 (IL-12), IFN-γ, and IL-6.
- The observed immune modulation suggests an enhanced innate and adaptive immune response.
Conclusions:
- CpG ODN 7909 demonstrates potent prophylactic activity against experimental glanders.
- This immunotherapy represents a promising approach for protecting individuals against biological attacks involving Burkholderia mallei.
- Further research into CpG ODN-based therapies is warranted for infectious disease and biodefense applications.
